Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438017 · ClinicalTrials.gov registry record · NA
Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia
A NA study of Insomnia, sponsored by Dreem.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 2
- Study locations
NCT05438017: Completed NA study of Insomnia, sponsored by Dreem.
NCT05438017 is a NA study of Insomnia that has completed, run by Dreem. The registered enrollment target is 41 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438017, a NA study of Insomnia, has completed, sponsored by Dreem.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of the clinical investigation is to assess the performance of the Dreem 3 System for sleep assessment compared to a FDA-cleared PSG assessment and human sleep expert scoring in a population experiencing insomnia symptoms.
Conditions Studied
Interventions
- DEVICE Dreem 3 System vs PSG
Study Locations (2)
New Jersey
- Biotrial Inc - Newark
Other
- Biotrial Rennes - Rennes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2022-07-08 |
| Phase | NA |
What the finished NCT05438017 record still lists
NCT05438017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Dreem 3 System vs PSG is the first listed.
NCT05438017 reports a single indexed study location in New Jersey, Other.
Frequently Asked Questions
What is clinical trial NCT05438017 about?
NCT05438017 is a clinical study titled "Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia". The objective of the clinical investigation is to assess the performance of the Dreem 3 System for sleep assessment compared to a FDA-cleared PSG assessment and human sleep expert scoring in a population experiencing insomnia symptoms.
What is the current status of trial NCT05438017?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-04-21. Estimated completion is 2022-07-08.
What conditions does trial NCT05438017 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT05438017?
The interventions under investigation include: Dreem 3 System vs PSG (DEVICE).
Who is sponsoring clinical trial NCT05438017?
This trial is sponsored by Dreem, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438017 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05438017's enrollment target sits among peer trials
41 114th of 151 higher than 38 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI